Ulipristal acetate in emergency contraception: Mechanism of action

Trends in Pharmacological Sciences

Volumn 34, Issue 4, 2013, Pages 195-196

  Mozzanega, Bruno ^a   Cosmi, Erich ^a   Nardelli, Giovanni Battista ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE; PLACEBO; PROGESTERONE RECEPTOR; ULIPRISTAL;

DRUG EFFICACY; DRUG MECHANISM; EMERGENCY CONTRACEPTION; HUMAN; LETTER; NIDATION; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL; SINGLE DRUG DOSE;

CONTRACEPTION, POSTCOITAL; CONTRACEPTIVE AGENTS; FEMALE; HUMANS; LUTEINIZING HORMONE; NORPREGNADIENES; OVARIAN FOLLICLE; OVULATION;

EID: 84876030923     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2013.02.003     Document Type: Letter

References (10)

1. A. Glasier Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis Lancet 375 2010 555 562
2. V. Brache Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture Hum. Reprod. 25 2010 2256 2263
3. P. Stratton A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women Hum. Reprod. 15 2000 1092 1099
4. P. Stratton Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914 Fertil. Steril. 93 2010 2035 2041
5. M.D. Passaro Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women Hum. Reprod. 18 2003 1820 1827
6. A.J. Wilcox Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby N. Engl. J. Med. 333 1995 1517 1521
7. P. Fine Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception Obstet. Gynecol. 115 2010 257 263
8. D.L. Blithe Development of the selective progesterone receptor modulator CDB-2914 for clinical indications Steroids 68 2003 1013 1017
9. R.A. Foulk Expression of L-selectin ligand MECA-79 as a predictive marker of human uterine receptivity J. Assist. Reprod. Genet. 24 2007 316 321
10. O.D. Genbacev Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface Science 299 2003 405 408